DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

12.14 -0.35 (-2.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACHN $12.14 -2.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.50
Previous Close $12.49
Daily Range $12.02 - $12.55
52-Week Range $2.45 - $16.87
Market Cap $1.2B
P/E Ratio -19.83
Dividend (Yield) $0.00 (0.0%)
Volume 5,399,315
Average Daily Volume 6,535,681
Current FY EPS -$0.67




Drug Makers


A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website:

News & Commentary

3 Tiny Biotech Stocks That I'm Paying Attention to in 2015

Achillion Pharmaceuticals Inc., Neuralstem Inc., and Prothena Corp. Plc could all announce news this year that could make shares climb or fall.

Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report

Achillion: The Dark Side

3 Biotech Stocks for Short-Term, Bullish Trades

Is Gilead Sciences Inc. Stock Cheap Now?

Gilead Sciences has fallen by double-digits from its 52-week high. Is the stock now too cheap to ignore?

Hep C Franchise Will Remain Key Midterm Driver For Gilead

Top 5 Biotech Stocks That The Smart Money Doesn't Like

Achillion Pharmaceuticals: A Strong Contender In A Crowded Space

Emergent BioSolutions Reports Positive Data on BioThrax - Analyst Blog

Emergent BioSolutions Reports Positive Data on BioThrax - Analyst Blog

Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi?

Achillion Pharmaceuticals is developing a short duration hepatitis C drug that could revolutionize treatment.

See More ACHN News...

ACHN's Top Competitors

ACHN $12.14 (-2.80%)
Current stock: ACHN
AMGN $157.72 (-0.79%)
Current stock: AMGN
GILD $103.53 (-0.63%)
Current stock: GILD
BIIB $409.59 (-0.12%)
Current stock: BIIB